Vernal Biosciences launches as mRNA manufacturer

By The Science Advisory Board staff writers

July 12, 2021 -- Vernal Biosciences has launched as a new mRNA manufacturer, supported by a round of seed funding led by Alloy Therapeutics.

The new firm is based in Burlington, VT, and was founded by CEO Christian Cobaugh, who has previously worked on mRNA development at Omega Therapeutics, Translate Bio, Arcturus Therapeutics, and Alexion Pharmaceuticals. It plans to use the funding for its technical development and commercial operations.

Vernal currently offers manufacturing-research-use mRNA and is scaling its manufacturing process that will become an advanced staging ground for clinical manufacturing projects, it said.


Copyright © 2021 scienceboard.net
 


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.